Evidence map›Paper›PMID 25466956›Full record

ArticleDigestive diseases and sciences2015

Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Nasser Ebrahimi Daryani, Maryam Sadr, Shirin Moossavi, Sepideh Shahkarami, Samaneh Soltani, Elham Farhadi, Nima Rezaei

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nasser Ebrahimi DaryaniDepartment of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, Iran.
Maryam Sadr
Shirin Moossavi
Sepideh Shahkarami
Samaneh Soltani
Elham Farhadi
Nima Rezaei

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimInterleukin (IL)-1 family members play an important role in the pathogenesis of inflammatory bowel disease (IBD). There are conflicting results regarding the association of IL-1 gene cluster single nucleotide polymorphisms (SNPs) with IBD and its clinical features. The aim of this study was to examine IL-1α -889 C/T, IL-1β -511 C/T, IL-1β +3962 C/T, IL-1R Pst-I1970 C/T, and IL-1RA Mspa-I11100 C/T SNPs in Iranian patients.

methodsIn this study, SNPs of IL-1 family members were investigated in 75 patients with IBD (40 CD and 35 UC), using polymerase chain reaction with sequence-specific primers method.

resultsIL-1β -511 CC genotype was significantly less present in UC compared to controls, while IL-1RA Mspa-I11100 CC was significantly associated with both Crohn's disease (CD) and ulcerative colitis (UC). IL-1α -889 TT genotype was more frequently associated with extraintestinal manifestations. A significant association was observed between IL-1β +3962 TT genotype and the disease activity in IBD. IL-1RA Mspa-I11100 CC was significantly less frequent in CD patients who need immunosuppressive therapy. IL-1RA Mspa-I11100 CT was associated with earlier age of onset in IBD, while TT genotype was associated with higher age of onset in IBD.

conclusionsIL-1 SNPs seem to be associated with IBD and could affect the disease severity as well.

Indexed as

Polymorphism, Single NucleotideAdultAge of OnsetColitis, UlcerativeCrohn DiseaseFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansImmunosuppressive AgentsInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinIranMaleIL1A protein, humanIL1B protein, humanIL1RN protein, humanImmunosuppressive AgentsInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist Protein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.